Edition:
United States

CVS Health Corp (CVS)

CVS on New York Consolidated

73.08USD
15 Dec 2017
Change (% chg)

$2.28 (+3.22%)
Prev Close
$70.80
Open
$71.33
Day's High
$73.68
Day's Low
$70.76
Volume
14,334,083
Avg. Vol
7,934,269
52-wk High
$84.72
52-wk Low
$66.45

Latest Key Developments (Source: Significant Developments)

Moody's says CVS-Aetna merger would have negative implications for other health care companies‍​
Monday, 4 Dec 2017 07:36pm EST 

Dec 4 (Reuters) - :Moody's: CVS-Aetna merger would have negative implications for other health care companies‍​.  Full Article

CVS nears majority cash deal for Aetna - CNBC
Thursday, 30 Nov 2017 09:29am EST 

Nov 30 (Reuters) - :CVS NEARS MAJORITY CASH DEAL FOR AETNA THAT COULD VALUE INSURER AT BETWEEN $200 AND $205 PER SHARE; DEAL COULD BE ANNOUNCED BY MONDAY- CNBC, CITING DJ.  Full Article

CVS Health sets goal of hiring 5,000 new apprentices by 2022​
Tuesday, 14 Nov 2017 08:00am EST 

Nov 14 (Reuters) - CVS Health Corp :CVS Health Corp - ‍has set a goal of hiring 5,000 new apprentices by 2022​.CVS Health Corp - ‍new goal of hiring new apprentices reflects expansion of co's registered apprenticeship program to seven additional states.  Full Article

Mckesson acquires RxCrossroads in a deal valued at $735 mln
Monday, 6 Nov 2017 04:16pm EST 

Nov 6 (Reuters) - Mckesson Corp ::Mckesson strengthens its portfolio of manufacturer solutions with the acquisition of RxCrossroads.Mckesson Corp - ‍transaction is valued at $735 million, or approximately $635 million net of present value of incremental cash tax benefits​.Mckesson Corp - ‍transaction will be funded by cash on hand​.Mckesson - ‍signed agreement to buy RxCrossroads from Cvs Health Corporation​.Mckesson Corp - ‍co expects impact of deal to be about 20 cents accretive to adjusted earnings per diluted share by third year following close of deal​.  Full Article

CVS Health in presentation- Expects FY revenue growth of 3.25-3.75 pct‍​
Monday, 6 Nov 2017 08:33am EST 

Nov 6 (Reuters) - CVS Health Corp :In presentation- expects FY revenue growth of 3.25-3.75 pct‍​.In presentation- expects FY PBM net revenue growth of 8-8.5 percent, adjusted gross margin to modestly decline.In presentation- expects FY retail net revenue to decline 2.25-2.75 percent, adjusted gross margin to modestly improve.In presentation- expects Q4 net revenue to grow 2.5-4.25 percent.In presentation- expects Q4 retail net revenue to decline 0.5-2.25 percent, comp sales to decline 1-2.75 percent.In presentation- expects Q4 pharmacy services revenue to grow 6-7.75 percent.  Full Article

CVS has proposed to acquire Aetna for more than $200 per share - CNBC, citing DJ‍​
Thursday, 26 Oct 2017 04:00pm EDT 

Oct 26 (Reuters) - :CVS has proposed to acquire AETNA for more than $200 per share - CNBC,citing DJ‍​.  Full Article

CVS Health in talks to buy Aetna - CNBC, citing DJ ‍​
Thursday, 26 Oct 2017 03:29pm EDT 

Oct 26 (Reuters) - ‍​:CVS Health in talks to buy Aetna - CNBC, citing DJ ‍​.  Full Article

CVS Health introduces new PBM performance-based pharmacy network
Tuesday, 24 Oct 2017 04:15pm EDT 

Oct 24 (Reuters) - CVS Health Corp :CVS Health introduces new PBM performance-based pharmacy network focused on reducing costs and improving clinical outcomes.Says ‍announced a new 30,000-store performance-based pharmacy network anchored by CVS Pharmacy and Walgreens​.Says ‍CVS Caremark will make this network available to eligible PBM clients for implementation beginning March 2018​.  Full Article

CVS Health signs five-year agreement with Anthem
Wednesday, 18 Oct 2017 06:10am EDT 

Oct 18 (Reuters) - CVS Health Corp ::CVS Health signs five-year agreement with anthem, inc. To provide services to support ingeniorx.CVS Health - ‍expects to incur implementation costs related to transition of members; costs expected to be immaterial to 2017 results​.CVS Health Corp -‍ CVS caremark will manage certain services for ingeniorx, including claims processing and prescription fulfillment​.CVS Health Corp - ‍new agreement, which goes into effect on January 1, 2020, runs through December 31, 2024​.  Full Article

CVS Health responds to opioid situation in the U.S.
Thursday, 21 Sep 2017 07:00am EDT 

Sept 21 (Reuters) - CVS Health Corp :CVS Health responds to opioid situation in the U.S..Says "in addition to our legacy opioid-abuse prevention programs, we are adding a new suite of tools‍​"‍​.Says adding in-store disposal units in 750 pharmacies, where consumers can drop off unwanted, unused medication for free disposal.Says ‍​CVS Caremark is "enhancing" utilization management program to ensure that opioids are being prescribed and used appropriately.  Full Article

Photo

CVS expects Justice Department to handle review of Aetna deal

WASHINGTON CVS Health Corp expects the U.S. Justice Department to do the antitrust review of its planned acquisition of health insurer Aetna Inc, a spokesman for the drugstore chain operator said.